Author: Zeyaullah, Md.; AlShahrani, Abdullah M.; Muzammil, Khursheed; Ahmad, Irfan; Alam, Shane; Khan, Wajihul Hasan; Ahmad, Razi
Title: COVID-19 and SARS-CoV-2 Variants: Current Challenges and Health Concern Cord-id: l57qu3ls Document date: 2021_6_15
ID: l57qu3ls
Snippet: The ongoing coronavirus disease 2019 (COVID-19) outbreak in Wuhan, China, was triggered and unfolded quickly throughout the globe by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The new virus, transmitted primarily through inhalation or contact with infected droplets, seems very contagious and pathogenic, with an incubation period varying from 2 to 14 days. The epidemic is an ongoing public health problem that challenges the present global health system. A worldwide social and e
Document: The ongoing coronavirus disease 2019 (COVID-19) outbreak in Wuhan, China, was triggered and unfolded quickly throughout the globe by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The new virus, transmitted primarily through inhalation or contact with infected droplets, seems very contagious and pathogenic, with an incubation period varying from 2 to 14 days. The epidemic is an ongoing public health problem that challenges the present global health system. A worldwide social and economic stress has been observed. The transitional source of origin and its transport to humans is unknown, but speedy human transportation has been accepted extensively. The typical clinical symptoms of COVID-19 are almost like colds. With case fatality rates varying from 2 to 3 percent, a small number of patients may experience serious health problems or even die. To date, there is a limited number of antiviral agents or vaccines for the treatment of COVID-19. The occurrence and pathogenicity of COVID-19 infection are outlined and comparatively analyzed, given the outbreak’s urgency. The recent developments in diagnostics, treatment, and marketed vaccine are discussed to deal with this viral outbreak. Now the scientist is concerned about the appearance of several variants over the globe and the efficacy of the vaccine against these variants. There is a need for consistent monitoring of the virus epidemiology and surveillance of the ongoing variant and related disease severity.
Search related documents:
Co phrase search for related documents- acid material and acute respiratory syndrome: 1, 2
- acid material and acute sars cov respiratory syndrome coronavirus: 1, 2
- acid monitoring and acute ards respiratory distress syndrome: 1
- acid monitoring and acute respiratory syndrome: 1, 2, 3
- acid monitoring and acute sars cov respiratory syndrome coronavirus: 1, 2
- actively replicate and acute respiratory syndrome: 1, 2, 3
- actively replicate and acute sars cov respiratory syndrome coronavirus: 1, 2, 3
- acute ards respiratory distress syndrome and adaptive immunity: 1, 2, 3, 4, 5, 6, 7
- acute respiratory syndrome and adapt ability: 1, 2, 3, 4, 5, 6
- acute respiratory syndrome and adaptive immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and adenosine nucleotide: 1, 2, 3
- acute respiratory syndrome and adenosine nucleotide analog: 1, 2
- acute respiratory syndrome and adenosine nucleotide analog prodrug: 1, 2
- acute respiratory syndrome and adjuvant immune response: 1, 2, 3, 4
- acute sars cov respiratory syndrome coronavirus and adaptive immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute sars cov respiratory syndrome coronavirus and adenosine nucleotide: 1, 2
- acute sars cov respiratory syndrome coronavirus and adenosine nucleotide analog: 1, 2
- acute sars cov respiratory syndrome coronavirus and adenosine nucleotide analog prodrug: 1, 2
- acute sars cov respiratory syndrome coronavirus and adjuvant immune response: 1
Co phrase search for related documents, hyperlinks ordered by date